MedTrace Logo

Blue Protocol Assessment

NCT04223297 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2023-01-18

No results posted yet for this study

Summary

Acute dyspnea is a common disease in emergency medicine. Mortality remains high is estimated at 15%. One third of initial diagnoses before paraclinical examination are estimated to be inaccurate. Lung ultrasound is a quick and immediate examination. Also, it is provided and performed at the bedside. The " Blue protocol " was designed by Daniel A. Lichtenstein as a diagnostic aid in dyspneic patients. It allows to obtain a diagnostic in more than 90% of acute dyspnea. However there is no validation in emergency medicine.

The main purpose is to evaluate the interest of the " Blue protocol "in the management and orientation of the dyspneic patient

Conditions

Interventions

PROCEDURE

lung ultrasound

The lung ultrasound will be performed by following the " Blue protocol "

Sponsors & Collaborators

  • Centre Hospitalier de Clermont

    collaborator UNKNOWN

  • Centre Hospitalier de Montreuil sur Mer

    collaborator UNKNOWN

  • Centre Hospitalier de Beauvais

    collaborator OTHER

  • Centre Hospitalier de Compiègne

    collaborator UNKNOWN

  • Centre Hospitalier de Doullens

    collaborator UNKNOWN

  • Centre Hospitalier de Abbeville

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-09-01
Completion
2020-09-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04223297 on ClinicalTrials.gov